These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19497347)

  • 1. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.
    González MC; Corton JC; Cattley RC; Herrera E; Bocos C
    Biochimie; 2009 Aug; 91(8):1029-35. PubMed ID: 19497347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agonist-induced down-regulation of hepatic glucocorticoid receptor via peroxisome proliferator-activated receptor in SD rats].
    Chen X; Li M; Sun WP; Bi Y; Cai MY; Liang H; Yu QQ; He XY; Weng JP
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3276-9. PubMed ID: 20193367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets.
    Ito Y; Yamanoshita O; Kurata Y; Kamijima M; Aoyama T; Nakajima T
    Arch Toxicol; 2007 Mar; 81(3):219-26. PubMed ID: 16937134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic peroxisome proliferator-activated receptor α may have an important role in the toxic effects of di(2-ethylhexyl)phthalate on offspring of mice.
    Hayashi Y; Ito Y; Yamagishi N; Yanagiba Y; Tamada H; Wang D; Ramdhan DH; Naito H; Harada Y; Kamijima M; Gonzales FJ; Nakajima T
    Toxicology; 2011 Oct; 289(1):1-10. PubMed ID: 21354252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related decrease in expression of peroxisome proliferator-activated receptor alpha and its effects on development of dyslipidemia.
    Ye P; Wang ZJ; Zhang XJ; Zhao YL
    Chin Med J (Engl); 2005 Jul; 118(13):1093-8. PubMed ID: 16098262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
    Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
    Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.
    Jeong S; Yoon M
    Obesity (Silver Spring); 2007 Jun; 15(6):1430-40. PubMed ID: 17557980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
    Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha.
    Shimakura J; Terada T; Saito H; Katsura T; Inui K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G851-6. PubMed ID: 16751172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
    Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F
    Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
    Zirlik A; Ernst S; Leugers A; Willecke F; Sobel BE; Bode C; Nordt TK
    Thromb Haemost; 2009 Jun; 101(6):1060-9. PubMed ID: 19492148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats.
    Toyama T; Nakamura H; Harano Y; Yamauchi N; Morita A; Kirishima T; Minami M; Itoh Y; Okanoue T
    Biochem Biophys Res Commun; 2004 Nov; 324(2):697-704. PubMed ID: 15474484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
    Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
    Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.
    LoVerme J; Russo R; La Rana G; Fu J; Farthing J; Mattace-Raso G; Meli R; Hohmann A; Calignano A; Piomelli D
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1051-61. PubMed ID: 16997973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
    Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
    Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor alpha (PPARalpha) activators induce hepatic farnesyl diphosphate synthase gene expression in rodents.
    Le Jossic-Corcos C; Pastori GM; Duclos S; Kawabe Y; Pineau T; Bournot P
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):203-11. PubMed ID: 15084352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.